Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Nicotine in Preventing COVID-19 Infection

NCT04583410 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04583410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04583410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Nicotine in Preventing COVID-19 Infection
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 3
Overall status
Unknown status
Start date
October 22, 2020
Completion date
June 30, 2022
Enrollment
1,633 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-associated coronavirus as cause of disease classified elsewhere